Background illustration for clinical trials search

Paid Clinical Trials Durham

Discover 1,668 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Safety of HRX215 in Patients After Minor and Major Liver Resection

for
Liver Resection, Colorectal Carcinoma Liver Metastases
Location: Durham NC, Baltimore MD, Cleveland OH, Rochester MN
Sponsor: HepaRegeniX GmbH

Sex: All

Age: 18 - 70+

Code: NCT06638502

Phase 1, Phase 2, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Durham NC, Chapel Hill NC, Richmond VA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase 3, Recruiting

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

for
Hematopoietic Stem Cell Transplant, CAR-T Cell Therapy
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18 - 70+

Code: NCT06575712

Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: Durham NC, Chapel Hill NC, Roanoke VA, Richmond VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase 3, Recruiting

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for
Cervical Cancer
Location: Durham NC, Greensboro NC, Kernersville NC,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT04831580

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

for
Breast Cancer, Breast Cancer Metastatic,
Location: Durham NC, Charlotte NC, Augusta GA, Atlanta GA,
Sponsor: Incyclix Bio

Sex: All

Age: 18+

Code: NCT05735080

Phase 1, Phase 2, Recruiting

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

for
Extensive-Stage Small Cell Lung Cancer
Location: Durham NC, Roanoke VA, Marietta GA, Cincinnati OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06646276

Phase 3, Recruiting
New

Lupus Nephritis Care Pathway

for
Lupus Nephritis (LN)
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07783152

Recruiting

Registry of Arthrex Hand and Wrist Products

for
Ulnar/Radial Collateral Ligament Reconstruction,
Location: Durham NC, Morgantown WV, Tuscon AZ, Phoenix AZ
Sponsor: Arthrex, Inc.

Sex: All

Age: 18+

Code: NCT05046600

Recruiting

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

for
Lung Transplant
Location: Durham NC, Baltimore MD, Philadelphia PA, Cincinnati OH,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 12+

Code: NCT06476132

Phase 2, Recruiting

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

for
Glioblastoma Multiforme
Location: Durham NC, Los Angeles CA, Santa Monica CA,
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT05708352

Phase 2, Recruiting

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

for
Neuroblastoma
Location: Durham NC, Charlotte NC, Richmond VA, Charleston SC,
Sponsor: Giselle Sholler

Sex: All

Age: 1 - 21

Code: NCT05489887

Phase 2, Recruiting

Hyperpolarized 129Xe MRI Lung Health Cohort

for
Healthy
Location: Durham NC, Iowa City IA, Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 25 - 35

Code: NCT05766384

Recruiting

Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

for
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS),
Location: Durham NC, Richmond VA, Washington D.C. DC,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 17

Code: NCT05267821

Phase 2, Phase 3, Recruiting

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

for
Myelofibrosis, Moderate Thrombocytopenia, Mild Thrombocytopenia
Location: Durham NC, Columbia MD, Cleveland OH, New York NY,
Sponsor: Karyopharm Therapeutics Inc

Sex: All

Age: 18+

Code: NCT05980806

Phase 2, Recruiting

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction

for
Heart Failure, Diastolic,
Location: Durham NC
Sponsor: Sardocor Corp.

Sex: All

Age: 50+

Code: NCT06061549

Phase 1, Recruiting

Statins and Breast Cancer Biomarkers

for
Breast Cancer
Location: Durham NC, Goldsboro NC, Newark DE, Boston MA,
Sponsor: University of Vermont

Sex: Female

Age: 35 - 55

Code: NCT00914017

Phase 2, Recruiting

Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial

for
Shoulder Dislocation, Glenohumeral Dislocation,
Location: Durham NC, Chapel Hill NC, Winston-Salem NC,
Sponsor: University of Pittsburgh

Sex: All

Age: 17 - 50

Code: NCT04809064

Recruiting

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

for
Autoimmune Diseases, Pregnancy Related,
Location: Durham NC
Sponsor: Duke University

Sex: Female

Age: 0+

Code: NCT03276923

Recruiting

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

for
Myelodysplastic Syndromes, Acute Myeloid Leukemia,
Location: Durham NC, Charleston SC, Atlanta GA, Columbus OH,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT04256317

Phase 2, Phase 3, Recruiting